Daniel Adelman, M.D.
Chief Medical Officer, Senior Vice President Development
Dr. Daniel C. Adelman joined Alvine Pharmaceuticals as Senior Vice President of Development and Chief Medical Officer in March of 2009. Before joining Alvine, Dr. Adelman was Senior Vice President of Development and Chief Medical Officer at Sunesis Pharmaceuticals, Inc. Prior to that, he served in various roles at Pharmacyclics, Inc., including Vice President of Clinical Operations and Biometrics and was a Clinical Scientist at Genentech, Inc. Dr. Adelman began his career at the University of California, San Francisco, School of Medicine, where he was Director of Clinical Allergy/Immunology in the Division of Allergy and Immunology. He continues to serve as Adjunct Professor of Medicine at UCSF. He holds a BA in Biology from the University of California, Berkeley and an M.D. degree from the University of California, Davis.
Meet Henk Kocken, Ph.D. >>
Back to management list >>